drugset / Trial / NCT03740516
Summary
This is an expanded access program (EAP) for eligible participants designed to provide access to CC-10004.
Timeline
- Start
- —
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Apremilast | Small molecule | — | Oral |